Charles Lin

Charles Lin

Directeur Technique/Scientifique/R&D chez KRONOS BIO, INC.

Fortune : 185 336 $ au 31/05/2024

39 ans
Health Technology
Finance
Consumer Services

Provenance du réseau au premier degré de Charles Lin

EntitéType d'entitéIndustrie
Public Company Pharmaceuticals: Major 28
Baylor College of Medicine
6
College/University Other Consumer Services 6

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Charles Lin via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
CELGENE Biotechnology

Jorge DiMartino

Katherine Stultz

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Norbert W. Bischofberger

Jorge DiMartino

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

GILEAD SCIENCES, INC. Biotechnology

Tai Yin Yang

John Martin

Norbert W. Bischofberger

Phillip Gutry

Roger Dansey

Marni Kottle

Corporate Officer/Principal

Chief Executive Officer

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Public Communications Contact

MERCK & CO., INC. Pharmaceuticals: Major

Christopher Dinsmore

Roger Dansey

Corporate Officer/Principal

Corporate Officer/Principal

TG THERAPEUTICS, INC. Pharmaceuticals: Major

David Tanen

Joshua Kazam

Director/Board Member

Director/Board Member

BAYER AG Pharmaceuticals: Major

Norbert W. Bischofberger

Marianne de Backer

Director/Board Member

Corporate Officer/Principal

Investment Managers

David Tanen

Joshua Kazam

Director/Board Member

Corporate Officer/Principal

Investment Managers

David Tanen

Joshua Kazam

Arie Belldegrun

Founder

Founder

Chairman

Pharmaceuticals: Major

David Tanen

Joshua Kazam

Founder

Director/Board Member

Investment Banks/Brokers

David Tanen

Joshua Kazam

Director/Board Member

Director/Board Member

Biotechnology

David Tanen

Joshua Kazam

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

John Martin

Barbara Kosacz

Director/Board Member

Director/Board Member

Stanford University College/University

Barbara Kosacz

Marni Kottle

Undergraduate Degree

Undergraduate Degree

University of Pennsylvania College/University

Philip J. Burguieres

Elena Ridloff

Masters Business Admin

Undergraduate Degree

College/University

Tai Yin Yang

John Martin

Doctorate Degree

Director/Board Member

Orion Biomedical Fund LP

David Tanen

Joshua Kazam

Corporate Officer/Principal

Chief Investment Officer

University of California, Davis College/University

Sandra Gardiner

Zung To

Undergraduate Degree

Undergraduate Degree

University of California San Diego College/University

Jorge DiMartino

Jennifer Nicholson

Doctorate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Tai Yin Yang

John Martin

Corporate Officer/Principal

Corporate Officer/Principal

ARNO THERAPEUTICS, INC. Pharmaceuticals: Major

David Tanen

Joshua Kazam

Arie Belldegrun

Founder

Founder

Chairman

Investment Managers

Arie Belldegrun

Rebecka Belldegrun

Founder

Chief Executive Officer

KITE PHARMA INC Biotechnology

David Tanen

Joshua Kazam

Arie Belldegrun

Christine Cassiano

Founder

Founder

Chief Executive Officer

Investor Relations Contact

Investment Managers

Otello Stampacchia

Roshawn Blunt

Founder

Consultant / Advisor

Data Processing Services

Christine Cassiano

Corporate Officer/Principal

UROGEN PHARMA LTD. Biotechnology

Arie Belldegrun

Christine Cassiano

Chairman

Consultant / Advisor

The Wharton School of the University of Pennsylvania College/University

Joshua Kazam

Phillip Gutry

Corporate Officer/Principal

Masters Business Admin

JUNO THERAPEUTICS INC Biotechnology

Otello Stampacchia

Director/Board Member

Biotechnology

Norbert W. Bischofberger

Otello Stampacchia

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Jakob Loven

Marianne de Backer

Director/Board Member

Director/Board Member

MORPHIC HOLDING, INC. Pharmaceuticals: Major

Norbert W. Bischofberger

Otello Stampacchia

Director/Board Member

Director/Board Member

VIR BIOTECHNOLOGY, INC. Biotechnology

Norbert W. Bischofberger

Marianne de Backer

Director/Board Member

Chief Executive Officer

Investment Managers

David Tanen

Joshua Kazam

Arie Belldegrun

Norbert W. Bischofberger

Christine Cassiano

Consultant / Advisor

Founder

Founder

Consultant / Advisor

Consultant / Advisor

ALLOGENE THERAPEUTICS, INC. Biotechnology

David Tanen

Joshua Kazam

Arie Belldegrun

Christine Cassiano

Founder

Founder

Founder

General Counsel

Miscellaneous Commercial Services

Joshua Kazam

Arie Belldegrun

Founder

Director/Board Member

Real Estate Investment Trusts

Joshua Kazam

Arie Belldegrun

Director/Board Member

Director/Board Member

Investment Managers

Joshua Kazam

Arie Belldegrun

Rebecka Belldegrun

Director/Board Member

Chairman

Director/Board Member

Breakthrough Services LLC

Joshua Kazam

Arie Belldegrun

Director/Board Member

Chairman

Financial Conglomerates

Joshua Kazam

Rebecka Belldegrun

Director/Board Member

Director/Board Member

Medical/Nursing Services

Tai Yin Yang

Elena Ridloff

Corporate Officer/Principal

Director of Finance/CFO

Biotechnology

Joshua Kazam

Arie Belldegrun

Jakob Loven

Founder

Founder

Director/Board Member

Financial Conglomerates

Joshua Kazam

Arie Belldegrun

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

David Tanen

Joshua Kazam

Arie Belldegrun

Founder

Founder

Founder

Investment Managers

Christopher Dinsmore

Jakob Loven

Corporate Officer/Principal

Corporate Officer/Principal

CAPRICOR THERAPEUTICS, INC. Pharmaceuticals: Major

David Tanen

Joshua Kazam

Arie Belldegrun

Corporate Secretary

Director/Board Member

Director/Board Member

Statistiques

Internationale

Etats-Unis 50
Allemagne 2

Sectorielle

Health Technology 25
Finance 13
Consumer Services 7
Commercial Services 5
Technology Services 2

Opérationnelle

Director/Board Member 196
Corporate Officer/Principal 85
Independent Dir/Board Member 48
Founder 39
Undergraduate Degree 26
  1. Bourse
  2. Insiders
  3. Charles Lin
  4. Connexions Sociétés